Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.

Gatalica Z, Lilleberg SL, Monzon FA, Koul MS, Bridge JA, Knezetic J, Legendre B, Sharma P, McCue PA.

Hum Pathol. 2011 Dec;42(12):1979-88. doi: 10.1016/j.humpath.2011.02.026. Epub 2011 Jul 5.

PMID:
21733559
2.

[The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].

Gong K, Zhang N, Na X, Wu G, Yang XY, Xin DQ, Na YQ.

Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):390-3. Chinese.

PMID:
15854350
3.

[Genetic backgrounds of renal cell carcinoma].

Oya M.

Nihon Rinsho. 2006 Feb;64 Suppl 2:593-6. Review. Japanese. No abstract available.

PMID:
16523961
4.

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU.

Cancer Res. 2001 Jul 1;61(13):5215-22.

5.

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

Rohan SM, Xiao Y, Liang Y, Dudas ME, Al-Ahmadie HA, Fine SW, Gopalan A, Reuter VE, Rosenblum MK, Russo P, Tickoo SK.

Mod Pathol. 2011 Sep;24(9):1207-20. doi: 10.1038/modpathol.2011.80. Epub 2011 May 20.

7.

Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.

Schmidt L, Li F, Brown RS, Berg S, Chen F, Wei MH, Tory K, Lerman I, Zbar B.

Cancer J Sci Am. 1995 Sep-Oct;1(3):191-5.

PMID:
9166475
9.

VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.

Lessi F, Mazzanti CM, Tomei S, Di Cristofano C, Minervini A, Menicagli M, Apollo A, Masieri L, Collecchi P, Minervini R, Carini M, Bevilacqua G.

Med Oncol. 2014 Mar;31(3):840. doi: 10.1007/s12032-014-0840-8. Epub 2014 Jan 21.

PMID:
24446253
10.

Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.

Khaliq S, Ajaz S, Firasat S, Shahid S, Hasan AS, Sultan G, Mohsin R, Hashmi A, Mubarak M, Naqvi SA, Rizvi SA, Mehdi SQ, Abid A.

Mutat Res. 2014 May-Jun;763-764:45-52. doi: 10.1016/j.mrfmmm.2014.03.008. Epub 2014 Apr 12.

PMID:
24727139
11.

Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.

He Z, Liu S, Guo M, Mao J, Hughson MD.

Cancer Genet Cytogenet. 2004 Jul 15;152(2):89-94.

PMID:
15262424
12.

Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene.

Baldewijns MM, van Vlodrop IJ, Smits KM, Vermeulen PB, Van den Eynden GG, Schot F, Roskams T, van Poppel H, van Engeland M, de Bruïne AP.

Cell Oncol. 2009;31(5):371-82. doi: 10.3233/CLO-2009-0482.

14.

VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.

von Teichman A, Compérat E, Behnke S, Storz M, Moch H, Schraml P.

Mod Pathol. 2011 Apr;24(4):571-8. doi: 10.1038/modpathol.2010.222. Epub 2010 Dec 10.

15.

Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.

Gomy I, Molfetta GA, de Andrade Barreto E, Ferreira CA, Zanette DL, Casali-da-Rocha JC, Silva WA Jr.

Fam Cancer. 2010 Dec;9(4):635-42. doi: 10.1007/s10689-010-9357-2.

PMID:
20567917
16.

[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].

Moch H.

Pathologe. 2008 Nov;29 Suppl 2:149-52. doi: 10.1007/s00292-008-1034-y. Review. German.

PMID:
18751708
17.

[Frequent somatic mutations of the von Hippel-Lindau (VHL) tumor suppressor gene and its meaning in sporadic human renal clear cell carcinoma].

Gong K, Zhang N, Guo HF, Zhang ZW, Xin DQ, Na YQ.

Beijing Da Xue Xue Bao. 2004 Apr;36(2):169-72. Chinese.

18.

Von Hippel-Lindau disease and sporadic renal cell carcinoma.

Zbar B.

Cancer Surv. 1995;25:219-32. Review.

PMID:
8718521
19.

The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.

Kaelin WG Jr.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s. Review.

20.

Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP, et al.

Am J Hum Genet. 1994 Dec;55(6):1092-102. Erratum in: Am J Hum Genet 1995 Jan;56(1):356.

Supplemental Content

Support Center